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Abstract
Background: The aims of this study were to identify the source and the transmission pathway for a Staphylococcal
Scalded Skin Syndrome (SSSS) outbreak in a maternity setting in Italy over 2 months, during 2014; to implement
appropriate control measures in order to prevent the epidemic spread within the maternity ward; and to identify
the Methicillin-Resistant Staphylococcus aureus (MRSA) epidemic clone.
Methods: Epidemiological and microbiological investigations, based on phenotyping and genotyping methods,
were performed. All neonates involved in the outbreak underwent clinical and microbiological investigations to
detect the cause of illness. Parents and healthcare workers were screened for Staphylococcus aureus to identify
asymptomatic carriers.
Results: The SSSS outbreak was due to the cross-transmission of a rare clone of ST5-CA-MRSA-SCCmecV-spa type t311,
exfoliative toxin A-producer, isolated from three neonates, one mother (from her nose and from dermatological lesions
due to pre-existing hand eczema) and from a nurse (colonized in her nose by this microorganism). The epidemiological
and microbiological investigation confirmed these as two potential carriers.
Conclusions: A rapid containment of these infections was obtained only after implementation of robust swabbing of
mothers and healthcare workers. The use of molecular methodologies for typing was able to identify all carriers and to
trace the transmission.
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Background
Staphylococcal Scalded Skin Syndrome (SSSS) describes
a spectrum of superficial blistering skin disorders
caused by the exfoliative (or epidermolytic) toxins of
Staphylococcus aureus, predominantly, but not exclu-
sively, affecting neonates and children under the age of
5 years [1].
Clinically, SSSS in children usually starts within
24–48 h with fever, irritability and widespread red-
ness of the skin, and fluid-filled blisters form that
rupture easily, leaving an area that looks like a burn.
Typical characteristics of the rash include: tissue-
paper-like wrinkling of the skin, followed by the ap-
pearance of large fluid-filled blisters in the armpits,
groin and body orifices such as the nose and ears;
the rash quickly spreads to other parts of the body
including the arms, legs and trunk. In newborns, le-
sions are often found in the diaper area, axillary
folds and around the navel; the top layer of skin be-
gins peeling off in sheets, leaving a moist, red and
tender area exposed. Other symptoms may include
weakness and dehydration [2–4].
In humans, SSSS is caused by the release of two
exfoliative epidermolytic toxins, ETA or ETB, from
Staphylococcus aureus toxigenic strains. These toxins
induce epidermal blistering through the cleavage of the
cell-cell adhesion molecule desmoglein-1, which is
only expressed by keratinocytes in the granular cell
layer, leading to a spectrum of illnesses ranging from
mild localized blistering to extensive generalized lesions
[2, 5]. ETs producing S. aureus strains have been associ-
ated with specific genetic backgrounds, on the basis of
their phage types, accessory gene regulator (agr) groups
and macrorestriction profiles [3–10].
SSSS in newborns has been mainly reported in clonal
complexes (CC) 121 and 15, carrying eta and/or etb
genes [2], but also in other less common genotypes, such
as ETB-positive ST91 MRSA and ETA-positive ST2993-
t211 (CC8) with and without SCCmecV [11, 12].
The prognosis in most cases is typically good if
prompt antibiotic therapy is given. Approximately 5% of
S. aureus strains produce exfoliative toxins, with a vari-
able prevalence index in different countries. In Europe,
the incidence of SSSS varies from 0.56 cases/million/
year in France, to 2.53 cases/million/year in the Czech
Republic [2, 3].
Recently, a nosocomial outbreak of SSSS has been de-
scribed in neonates in England sustained by S. aureus
isolates belonging to spa-type t346 [2].
Our study reports the experience of an SSSS outbreak,
due to the cross transmission of a methicillin-resistant
S.aureus isolate belonging to a rare clone of ST5-CA-
MRSA-SCCmecV-spa type t311, ETA toxin producer,
among three infants hospitalized in the maternity ward
of an Italian hospital. Rapid containment of these infec-
tions was obtained only after implementation of robust
swabbing of healthcare workers, and the use of molecu-
lar methodologies for typing that was able to identify
carriers and to trace the transmission.
The aims of this study were: i) to identify the causative
agent and the transmission pathway; ii) to enforce cor-
rect control measures avoiding the spread within the




The outbreak occurred in the Maternity Unit of the
hospital “Dell’Angelo” in Mestre (Venice), Italy, with 40
beds, about 1,800 delivers per year, 7 delivery rooms, 2
operating rooms and one nursery, where the neonates
stay when they are not in the room with their mother.
The Maternity Unit has 112 Health Care Workers
(HCW).
Clinical investigations
During the cluster period, from November 20 to
December 4, 2014, from the date of the first birth to
the date of the discharge of the third newborn, 66 neo-
nates were born in the unit. Umbilical swabs and other
skin lesion swabs were performed on neonates presenting
with clinical scalded skin syndrome signs. During the hos-
pital admission, the neonates affected by SSSS were cared
for in single rooms with their parents and swabs and
digital photographs of skin lesions were taken.
Parent and staff screening investigations
Parents and relatives of the ill new-borns were screened
by nasal swabs, and hand swabs only in cases of skin
lesions.
The maternity staff screening for S. aureus carriers
started on December 6 by nasal swabs. Visual hand in-
spection and anamnesis research for hand skin diseases
were conducted among the operators involved in the
sick neonates’ pathway from the delivery room to the
nursery and mothers’ room. All staff voluntarily com-
plied with the request for screening.
Infection control measures
During the progress of the investigation, the following
control measures were applied: (i) immediate repetition
to all the operators about contact measures for the pre-
vention of infectious diseases and recommendation to
the nursery operators to use a hand wash with a hydro-
alcoholic solution before handling each neonate; (ii) im-
mediate use of barrier measures (masks and gloves) for
all the operators, until the identification of the index
case. Operators usually used gloves only during delivery;
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(iii) immediate onset of screening to find S. aureus car-
riers; (iv) on December 9, extraordinary environmental
sanitation in delivery rooms, nursery and ward rooms.
In the nursery, in addition to the classic cleaning pro-
cedures, on December 18, a hydrogen peroxide and
silver cation nebulization machine was used; (v) from
December 12, topic mupirocin treatment was applied;
(vi) on December 23 and January 8, two meetings with
doctors, nurses, midwifes and support staff were held
for clinical audit about the procedures followed from
delivery to the neonates hospital discharge and discus-
sion about the strategy used.
Microbiological investigations
Nose and hand swabs were collected from doctors, nurses,
midwives and support staff involved in the sick newborns’
management, from the delivery room to the nursery, as
well as from the neonates’ parents and from the skin
lesions of the sick newborns. All samples were cultured
on Columbia Blood Agar (CBA) and Mannitol Salt Agar
(MSA) plates (Becton Dickinson GmbH, Heidelberg,
Germany); colony identification was obtained using co-
agulase test and Vitek2 GP card (BioMerieux, Marcy-
L’Etoile, France) and Aris Sensititre ITGPOSF was used
for susceptibility tests (Trek Diagnostics, Cleveland,
OH, USA).
All the culture plates positive for S. aureus were sent
to the “Medical Molecular Microbiology and Antibiotic
Resistance” reference laboratory (M.M.A.R.L. http://
www.labmicrobiologia.unict.it), Department of Biomedical
and Biotechnological Science (BIOMETEC), University of
Catania, for further characterization.
Methicillin resistance was re-evaluated by the cefoxitin
disk diffusion method and correlated with the presence of
the mecA gene, as suggested by the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) and
Clinical and Laboratory Standards Institute (CLSI) guide-
lines [13, 14]. The antimicrobial susceptibilities were
evaluated in agreement with the EUCAST interpret-
ation criteria [13]. The S.aureus isolates were also
screened by population analysis (PAP/AUC) to verify
the presence of vancomycin-intermediate (VISA) and
heteroresistant vancomycin-intermediate S. aureus (hVISA)
phenotypes [15].
Molecular typing, agr locus and the virulence gene
content (adhesion and toxin genes) were performed as
previously described [16–20]. Representative S. aureus
control strains were included in the study for phenotypic
and genotypic assays [16, 17].
Results
Clinical presentation of the outbreak and case series
The outbreak of SSSS infections occurred in neonates
from November to December 2014 in the Maternity
Unit of the hospital “Dell’Angelo” in Mestre (Venice),
Italy.
Three cases were identified over a 2-month period.
Patients were born from 20 to 25 November 2014. All
hospitalization periods overlapped, suggesting possible
cross-transmission from one neonate to another.
In all cases, the skin symptoms began after 3–9 days
from birth. After birth, they were discharged but returned
to the hospital in 2–5 days. After four days from the ad-
mission of the third neonate, the Medical Chief of the
pediatrics department reported this to the hospital
Director of the Infectious Control Team (ICT) who
then activated a Task Force for the epidemiological and
microbiological investigation. All patient skin swabs
were positive for MRSA. Blood cultures remained nega-
tive. None of the neonates required intensive care after
delivery and none had an invasive procedure.
Screening investigations
During hospitalization, several control measures were im-
plemented to prevent epidemic spread and an attempt
was made to identify the source of pathogen transmission.
Multiple samples were collected from neonate mothers
and from the hospital staff.
Among the mothers, case 1 mother had dermato-
logical lesions due to pre-existing hand eczema. On
December 12, she was found positive for MRSA strains
by the rapid Vitek identification method, both in her
nose and on her hands. Case 2 mother was not colo-
nized by S.aureus. Case 3 mother was found positive for
S.aureus by nasal swab.
Twenty-seven HCW (24.1%) were positives for S. aureus,
3 (2.7%) of them for MRSA. On December 12, the treat-
ment with nasal mupirocin was started (twice a day, for
5 days) only for those operators that were MRSA positive,
and those that were waiting for the microbiological re-
sponse from the laboratory. Only for the carriers of the
same cluster strain, was a new control swab taken after
5 days from the end of therapy. They were successfully
decolonized. No further neonate or staff-member has been
identified with MRSA strains to date; the last controls were
made on 25 March, 2015.
Microbiological characteristics
In the course of the neonatal, parent and staff screening in-
vestigations, 9 S.aureus strains from affected skin regions,
nasal swabs and carriers were isolated and sent to the refe-
rence lab (MMARL) of the BIOMETEC Department of the
University of Catania, for further characterizations.
The microbiological and molecular characteristics of
the sample in study are shown in Table 1.
Seven out of the 9 swab cultures yielded methicillin-
resistant S.aureus, only resistant to beta-lactams and
susceptible to levofloxacin, gentamicin, erythromycin,
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clindamycin, trimethoprim-sulfamethoxazole, tetracyc-
line and rifampicin. The MIC values for the main anti-
Gram positive drugs (linezolid, vancomycin, teicoplanin
and daptomycin) were in the range of full susceptibility.
Population analysis confirmed that all strains were
vancomycin-susceptible, without glycopeptides heterore-
sistant sub-populations.
Two methicillin-susceptible S.aureus strains (MSSA),
mecA gene negative and cefoxitin susceptible, and sus-
ceptible to all antimicrobials tested, were found in case 3
mother and in a staff-member.
All strains isolated from the three neonates, the case 1
mother (index-case) and one nurse showed a typical
CA-MRSA phenotype and belonged to the same clone
ST5-SCCmecV-spa type t311, with the same PFGE profile
C (subtypes C1 and C2) and agr-locus II. The virulence
gene content revealed that all isolates were positive for the
eta gene, encoding for the epidermolytic toxin responsible
for SSSS, and positive for lukE, icaA, fnbA, sej genes. No
other toxin genes were present in these cases, including
lukS-lukF (Panton-Valentine leukocidin), tst, sea, seb, sec,
sek/q genes and the ACME-locus.
Two staff members were found to carry two non-
outbreak MRSA strains, belonging to ST5-SCCmec IV-
t1094 agrII (formerly pediatric or USA800 HA-MRSA
clone) and ST8-SCCmec II-t3240 agrI (formerly Irish
clone). They had different PFGE-types (A and B), and
possessed the same toxin gene content with the addition
of the Panton-Valentine Leukocidin gene.
Discussion
Our study describes an outbreak of SSSS in a maternity
setting in Italy over 2 months during 2014.
Surveillance of the staff members by nasal swabs iden-
tified S.aureus carriage in 24.1% of HCW. This percent-
age is close to those reported by other authors from
Ireland (30%) and England (21%) [2, 3, 21–23]. MRSA
strains were found on three nurses (2.7%), of which only
one showed the characteristics of the outbreak strain. It
was possible to eradicate S. aureus and the nurse was
still decolonized after 4 months. After an accurate ana-
lysis of the work shifts, it was possible to establish that
the operator was always on duty during the care of the
three ill newborns in the nursery.
The molecular characterization highlighted the spread
of a rare CA-MRSA clone ST5-spa type t311, unusually
associated with the SCCmecV cassette of veterinary
origin. This association has rarely been described in the
literature [24]. This clone (already known as USA800 or
pediatric clone) is usually associated with the SCCmec
IV element, and it is widely spread in both hospitals and
the community [25]. From these data, it can be assumed
that there was a possible horizontal transfer of the
SCCmec V cassette in a different genetic background,
commonly diffused in the hospital setting.
In this study, ST5-SCCmecV-spa-type t311 epidemic
strains producing ETA toxin, isolated from the three neo-
nates, case 1 mother and the nurse were indistinguishable.
Retrospectively, based on the microbiological and mo-
lecular data, two different routes can explain this neo-
nate infection. The mother of one of the newborns was
affected by chronic eczema, and was found to carry the
epidemic strain; she might have been an asymptomatic
carrier on admission to the unit, and she might have in-
fected her child. Nasal, axillar and perianal carriage of
S.aureus strains producing epidermolytic toxin have been
reported in 3% of pregnant women [26, 27]. Moreover,
Table 1 Clinical and microbiological characteristics of MRSA/MSSA isolates from SSSS and contact screening
Code Date of
isolate
Case type Clinical feature Case definition Speciment PFGE type agr type ST-SCCmec-spa
type
Toxin genes detected
lukE lukS/F eta icaA fnbA
s1 06/12/2014 staff NC Colonized Nares C1 II 5-V-t311 + - + + +
s2 09/12/2014 staff NC Colonized Nares A II 5-IV-t1094 + + + + +
s3 10/12/2014 staff NC Colonized Nares B I 8-II-t3240 + + + + +
s4 11/12/2014 staff NC Colonized Nares D III mecA negativeb + - - + +
n 1 02/12/2014 neonate SSSS Infected Affected skin
(jaw, gluteus)
C1 II 5-V-t311 + - + + +
n 2 29/11/2014 neonate SSSS Infected Affected
skin-groin
C2 II 5-V-t311 + - + + +
n 3 04/12/2014 neonate SSSS Infected Affected
skin - leg
C2 II 5-V-t311 + - + + +
m 1 06/12/2014 mother aSSTI Infected ? Nares, hand
lesions
C2 II 5-V-t311 + - + + +
m 3 09/12/2014 mother NC Colonized Nares E I mecA negativeb - - - + +
NC no clinical signs, SSSS staphylococcal scaled skin sindrome, agr accessory gene regulator locus, ST sequence type, SCCmec staphylococcal chromosomal cassette
aSSTI: dermatological lesion (hand eczema); bMLST and spa-typing were restricted only to methicillin-resistant isolates
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atopic chronic dermatitis (also known as atopic eczema)
has been recognized as an important source of skin infec-
tion, responsible for the dissemination of S.aureus in
hospitals [28].
The other possibility is that the nurse was the source
of the epidemic strain and might have infected the three
neonates, one of which might have infected its own
mother. In hospitals and in nurseries, outbreaks of
staphylococcal infections are expected to originate from
asymptomatically colonized care attendants rather than
mothers [29, 30].
Conclusions
The validity of this survey was to promptly find the causa-
tive agent of SSSS, to prevent the spread of the pathogen
within the hospital ward, and to identify the MRSA epi-
demic clone. In fact, the available mitigation measures,
such as screening of parents and hospital staff that was
immediately implemented, stopped the epidemic in less
than a week after onset.
The immediate implementation of strong barrier mea-
sures was enough to break the spread of the infection. The
nurse, decolonized after some months, is still employed in
the same department.
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